1. Home
  2. AXSM vs CCOI Comparison

AXSM vs CCOI Comparison

Compare AXSM & CCOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXSM
  • CCOI
  • Stock Information
  • Founded
  • AXSM 2012
  • CCOI 1999
  • Country
  • AXSM United States
  • CCOI United States
  • Employees
  • AXSM N/A
  • CCOI N/A
  • Industry
  • AXSM Biotechnology: Pharmaceutical Preparations
  • CCOI Telecommunications Equipment
  • Sector
  • AXSM Health Care
  • CCOI Consumer Discretionary
  • Exchange
  • AXSM Nasdaq
  • CCOI Nasdaq
  • Market Cap
  • AXSM 6.2B
  • CCOI 3.6B
  • IPO Year
  • AXSM 2015
  • CCOI N/A
  • Fundamental
  • Price
  • AXSM $119.45
  • CCOI $69.94
  • Analyst Decision
  • AXSM Strong Buy
  • CCOI Buy
  • Analyst Count
  • AXSM 14
  • CCOI 9
  • Target Price
  • AXSM $168.64
  • CCOI $83.00
  • AVG Volume (30 Days)
  • AXSM 915.7K
  • CCOI 395.8K
  • Earning Date
  • AXSM 05-05-2025
  • CCOI 02-27-2025
  • Dividend Yield
  • AXSM N/A
  • CCOI 5.68%
  • EPS Growth
  • AXSM N/A
  • CCOI N/A
  • EPS
  • AXSM N/A
  • CCOI N/A
  • Revenue
  • AXSM $385,693,000.00
  • CCOI $955,704,000.00
  • Revenue This Year
  • AXSM $65.06
  • CCOI $11.02
  • Revenue Next Year
  • AXSM $63.84
  • CCOI $7.45
  • P/E Ratio
  • AXSM N/A
  • CCOI N/A
  • Revenue Growth
  • AXSM 42.53
  • CCOI 7.30
  • 52 Week Low
  • AXSM $64.11
  • CCOI $50.80
  • 52 Week High
  • AXSM $139.13
  • CCOI $86.76
  • Technical
  • Relative Strength Index (RSI)
  • AXSM 48.15
  • CCOI 32.91
  • Support Level
  • AXSM $116.00
  • CCOI $69.00
  • Resistance Level
  • AXSM $128.43
  • CCOI $72.68
  • Average True Range (ATR)
  • AXSM 5.08
  • CCOI 2.86
  • MACD
  • AXSM -2.27
  • CCOI -0.86
  • Stochastic Oscillator
  • AXSM 14.92
  • CCOI 8.84

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

About CCOI Cogent Communications Holdings Inc.

Cogent carries over one fifth of the world's internet traffic over its network and is a broadband provider for businesses. Cogent's corporate customers are in high-rise office buildings; the firm provides them with two types of connections: dedicated internet access, which connects them to the internet, and virtual private networking, which offers an internal network for employees in different locations. Cogent's corporate customers are exclusively in North America and account for over half of the firm's revenue. Cogent's netcentric customers include internet service providers and content providers, to which Cogent provides internet transit. They hand traffic to Cogent in data centers and rely on Cogent to deliver it. About half of netcentric revenue is from outside the US.

Share on Social Networks: